Surzebiclimab (BGB-A425) is a humanized monoclonal antibody specifically targeting TIM-3 (T-cell immunoglobulin and mucin domain containing -3), exhibiting high affinity (KD=0.36 nM) for the extracellular domain of human TIM-3. It is applicable for investigating advanced malignancies.
Reinheit:
95.00%
CAS Nummer:
[2342597-90-2]
Target-Kategorie:
Immunology/Inflammation related
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten